Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HDC to develop breast cancer prognostic test

This article was originally published in Clinica

Executive Summary

Pattern recognition technology specialist Health Discovery Corporation (HDC) is set to team up with Smart Personalized Medicine (SPM) to develop a breast cancer test. The two firms will create the test using HDC’s support vector machine (SVM) technology and will collaborate with the MD Anderson Cancer Center in Houston, Texas, for the product’s development. This partnership will see HDC (Savannah, Georgia) receive a 15% equity stake in SPM, as well as a $5m initial investment from its new partner. HDC will also receive a royalty for each test sold of up to 7.5% based on net proceeds. No further financial details were disclosed. According to HDC, its SVM technology allows scientists to access information in micro-array datasets that more advanced bioinformatics techniques miss. SPM was formed by former Integra Life Sciences chairman Dr Richard Caruso.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043286

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel